Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psychoeducational Intervention and Open-Label Placebo for Cancer-Related Fatigue
NCT06085716Phase 3Recruiting
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Feb 2024
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial (3 arms), sponsored by University of Texas MD Anderson Cancer Center. Primary endpoint: Incidence of Adverse Events at 1 year. Started Feb 2024; status: recruiting.
Beyond the preview
Go deeper on NCT06085716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06085716.